# Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/durvalumab-after-chemoradiotherapy-in-stage-iii-non-small-cell-lung-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Scott Antonia,Augusto Villegas,Davey B. Daniel,David Vicente,Shuji Murakami,Rina Hui,Takashi Yokoi,Alberto Chiappori,Ki Hyeong Lee,Maike de Wit,Byoung Chul Cho,Maryam Bourhaba,Xavier Quantin,Takaaki Tokito,Tarek Mekhail,David Planchard,Young‐Chul Kim,Christos S. Karapetis,Sandrine Hiret,Gyula Ostoros,Kaoru Kubota,Jhanelle E. Gray,Luis Paz‐Ares,Javier de Castro,Catherine Wadsworth,Giovanni Melillo,Haiyi Jiang,Yifan Huang,Phillip A. Dennis,Mustafa Özgüroğlu |
| Citations | 4,592 |
| DOI | 10.1056/nejmoa1709937 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1709937?articleTools=true |
| OpenAlex ID | https://openalex.org/W2753065806 |
| PMID | 28885881 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Jhanelle E. Gray](https://scholariq.org/researchers/jhanelle-e-gray/)
- [David Planchard](https://scholariq.org/researchers/david-planchard/)
- [Alberto Chiappori](https://scholariq.org/researchers/alberto-chiappori/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.